Nicole Thomson
About Nicole Thomson
Nicole Thomson is an Oncology Institution Tumor Specialist at Bristol Myers Squibb with over 20 years of experience in the pharmaceutical industry, focusing on oncology and virology.
Current Position at Bristol Myers Squibb
Nicole Thomson is currently employed at Bristol Myers Squibb as an Oncology Institution Tumor Specialist. She operates out of the San Francisco Bay Area. Her role in oncology leverages her comprehensive background in virology and community health, enabling her to contribute significantly to the field.
Previous Roles at Bristol Myers Squibb
Nicole Thomson has held several positions within Bristol Myers Squibb, including Senior Territory Business Manager Oncology from 2016 to 2021 and Senior Territory Business Manager Virology from 2015 to 2016, based in the San Francisco Bay Area. Earlier in her career, she worked as Virology Senior Territory Business Manager from 2003 to 2009 in the New York City Metropolitan Area. These roles allowed her to develop deep expertise in managing business operations and territories in both oncology and virology.
Experience at Gilead Sciences
From 2009 to 2014, Nicole Thomson worked at Gilead Sciences as a Product Specialist. During her five-year tenure in the San Francisco Bay Area, she honed her skills in product management and gained valuable experience in the pharmaceutical industry.
Educational Background
Nicole Thomson holds a Master of Public Health (MPH) in Community Health and Preventive Medicine from New York University, earned between 2000 and 2002. She also obtained a Bachelor of Arts (BA) in Sociology from the University of California, San Diego. Her educational background provides a solid foundation for her work in community health and preventive medicine, complementing her roles in oncology and virology.
Industry Experience and Expertise
With over 20 years of experience in the pharmaceutical industry, Nicole Thomson has developed substantial expertise in both oncology and virology. Her career includes significant roles managing territories and business operations. Transitioning from virology to oncology within Bristol Myers Squibb, she showcases versatility in handling different therapeutic areas. Her strong background in community health and preventive medicine enhances her contributions to the oncology field.